Novartis India Share Price in 2018: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2018?

Let's find out!

Novartis India share price in 2018 was ₹720.3 Its price on 1st January 2018 was ₹645, and by 31st December 2018 it moved to ₹720.3, giving a positive return of 11.67% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2018 are as follows:

Open	High	Low	Close
₹645	₹980	₹590	₹720.3
1st Jan 2018	Occured in Aug 2018	Occured in Mar 2018	31st Dec 2018

This page will help you understand how Novartis India performed in 2018. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2018

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹639.54	-	↑ ₹675 ↓ ₹636.25
Feb	₹634.7	-0.8%	↑ ₹647.04 ↓ ₹598
Mar	₹612.29	-3.6%	↑ ₹669.5 ↓ ₹590
Apr	₹665	8.6%	↑ ₹669 ↓ ₹604.65
May	₹662.35	-0.4%	↑ ₹682 ↓ ₹600.2
Jun	₹667.65	0.8%	↑ ₹729 ↓ ₹621
Jul	₹635.7	-4.8%	↑ ₹688 ↓ ₹615
Aug	₹944.7	48.6%	↑ ₹980 ↓ ₹616.54
Sep	₹747.35	-20.9%	↑ ₹974.85 ↓ ₹738.8
Oct	₹717.65	-4%	↑ ₹770.95 ↓ ₹666.05
Nov	₹693.4	-3.4%	↑ ₹789.9 ↓ ₹670
Dec	₹720.3	3.8%	↑ ₹769 ↓ ₹680.55

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2018?

In 2018, the opening price of Novartis India share was ₹645.00. Today, the price stands at ₹672.25, reflecting a growth of 4.22%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2018 would have become ₹10,422.48 by 2025. This represents a CAGR of 0.59%.

---

You might also like to check: Novartis India Stock Price in 2017 or Novartis India Stock Price in 2019

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.